ARUP offers a comprehensive menu to assess patients with kidney stone disease. Calculi (stone) testing specializes in two areas that provide valuable information to determine appropriate treatment and course of patient care:

1. Assessing and monitoring the risk of stone formation (urine studies)

2. Evaluating stone composition


  • Approximately 11 percent of adults in the United States will develop kidney stones in their lifetime. These rates double in patients with a family history of stones.
  • Men are two to three times more likely than women to experience kidney stones.
  • The five-year recurrence rate is reported to be as high as 50 percent after the first episode.
  • Incidence of this disease is rising and estimated to cost $5.3 billion per year in healthcare dollars.